FGF-2 (Fibroblast growth factor-2 or basic FGF)                                                                                                                                           Price

BACKGROUND: Fibroblast growth factor-2 (FGF-2 or b-FGF) belongs to the FGF family of more than 20 growth factors possessing broad
mitogenic and angiogenic activities through differential interactions with four major tyrosine kinase FGF receptors. Cross-talk mechanisms exist
among FGF-2 and different members of the VEGF family during angiogenesis and vasculogenesis. This property has implicated FGF-2 in diverse
areas of preclinical studies such as tumor growth, vascular and bone remodeling, and cardiac hypertrophy. Multiple forms of FGF-2 are generated
by alternative translation on the same mRNA transcript, producing a low molecular weight (LMW ~18 kDa) and several high molecular weight (HMW
20-24 kDa) forms from AUG (methionine) and CUG (leucine) codons, respectively. All FGF-2 forms lack a classical signal peptide that directs
secretion through the endoplasmic reticulum-Golgi pathway. The recombinant human FGF2 is expressed as a GST-fusion protein. The fusion
junction of the protein harbors an engineered thrombin cleavage site and a protein kinase A (PKA) phosphorylation site. The GST portion of the
fusion protein can be cleaved off by thrombin if necessary. The fusion protein can be radioactively labeled with 32P-r-ATP and PKA.
Site Map
Biomedical Research Service
& Clinical Application
Alphabetical Listing